Technical Analysis for HBIO - Harvard Bioscience, Inc.

Grade Last Price % Change Price Change
F 3.57 0.28% 0.01
HBIO closed down 3.52 percent on Thursday, April 25, 2024, on 74 percent of normal volume. The bears made the stock sink to a new 52-week low. Due to the stock's strong downtrend, it may remain oversold for a while. So, if you're looking for a reason to buy, don't put too much weight on it being oversold.
0 Watchers
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Strong Down Down Down

Date Alert Name Type % Chg
New 52 Week Closing Low Bearish 0.28%
Lower Bollinger Band Walk Weakness 0.28%
New 52 Week Low Weakness 0.28%
Lower Bollinger Band Touch Weakness 0.28%
Oversold Stochastic Weakness 0.28%
New 52 Week Closing Low Bearish -3.25%
NR7 Range Contraction -3.25%
Narrow Range Bar Range Contraction -3.25%
Lower Bollinger Band Walk Weakness -3.25%
Earnings Movers Other -3.25%

   Recent Intraday Alerts

Alert Time
Up 5% about 2 hours ago
Rose Above Previous Day's High about 3 hours ago
Up 3% about 3 hours ago
Up 2% about 3 hours ago
Up 1% about 3 hours ago

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Harvard Bioscience, Inc. Description

Harvard Bioscience, Inc., together with its subsidiaries, develops, manufactures, distributes, and markets specialized products, primarily apparatus and scientific instruments used to advance life science research and regenerative medicine. It operates through two segments, Life Science Research Tools and Regenerative Medicine Device. The company's products primarily target ADMET testing and molecular biology application areas. Its ADMET testing products include absorption diffusion chambers that measure the absorption of a drug into the bloodstream; well equilibrium dialysis plate for serum protein binding assays; organ testing systems; infusion pumps; behavioral products used in neuroscience, cardiology, psychological, and respiratory studies to evaluate the effects of situational stimuli, drugs, and nutritional infusions on motor and sensory, activity, and learning and test behavior; cell injection systems; ventilators; and electroporation products. The company's molecular biology products include molecular biology spectrophotometers, DNA/RNA/protein calculators, multi-well plate readers, liquid dispensers, and amino acid analysis and gel electrophoresis systems, as well as liquid handling consumables, such as pipettes, pipette tips, autoradiography films, gloves, thermal cycler accessories, and reagents. It also distributes devices, instruments, and consumables used in experiments involving cells, tissues, organs, and animals in the fields of proteomics, physiology, pharmacology, neuroscience, cell biology, molecular biology, and toxicology; and manufactures microdialysis products, synthetic scaffolds, bioreactors, and cell biology and electrophysiology products. The company sells its products to pharmaceutical and biotechnology companies, universities, and government laboratories through distributors, catalogs, and its field sales organization and Website worldwide. Harvard Bioscience, Inc. was founded in 1901 and is headquartered in Holliston, Massachusetts.


Classification

Sector: Healthcare
Industry: Medical Instruments & Supplies
Keywords: Biotechnology Biology Acid Natural Sciences Neuroscience Molecular Biology Cell Biology Pharmacology Dialysis Cardiology Regenerative Medicine Infusion Pump Toxicology Organs Physiology Proteomics Electrophysiology Specialized Products Oral Products Radiography E Readers Search Tool Dialysis Products Electrophysiology Products Electroporation Gel Electrophoresis Harvard

Is HBIO a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 6.28
52 Week Low 3.47
Average Volume 88,106
200-Day Moving Average 4.47
50-Day Moving Average 4.26
20-Day Moving Average 4.13
10-Day Moving Average 3.93
Average True Range 0.26
RSI (14) 33.77
ADX 32.73
+DI 8.94
-DI 27.07
Chandelier Exit (Long, 3 ATRs) 3.91
Chandelier Exit (Short, 3 ATRs) 4.26
Upper Bollinger Bands 4.74
Lower Bollinger Band 3.53
Percent B (%b) 0.03
BandWidth 29.37
MACD Line -0.18
MACD Signal Line -0.10
MACD Histogram -0.0723
Fundamentals Value
Market Cap 151.97 Million
Num Shares 42.7 Million
EPS -0.08
Price-to-Earnings (P/E) Ratio -44.50
Price-to-Sales 1.82
Price-to-Book 2.74
PEG Ratio 2.89
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 3.90
Resistance 3 (R3) 3.91 3.80 3.84
Resistance 2 (R2) 3.80 3.71 3.80 3.82
Resistance 1 (R1) 3.68 3.66 3.63 3.67 3.80
Pivot Point 3.58 3.58 3.55 3.57 3.58
Support 1 (S1) 3.46 3.49 3.40 3.45 3.32
Support 2 (S2) 3.35 3.44 3.35 3.30
Support 3 (S3) 3.23 3.35 3.28
Support 4 (S4) 3.22